Issued Patents All Time
Showing 1–25 of 97 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12083101 | Biaryl derivatives as YAP/TAZ-TEAD protein-protein interaction inhibitors | Vincent BORDAS, Cara BROCKLEHURST, Patrick Chene, Vito Guagnano, Patricia Imbach-Weese +10 more | 2024-09-10 |
| 10786492 | Formylated N-heterocyclic derivatives as FGFR4 inhibitors | Nicole Buschmann, Robin Alec Fairhurst, Thomas Knoepfel, Catherine Leblanc, Robert Mah | 2020-09-29 |
| 10507201 | Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors | Nicole Buschmann, Robin Alec Fairhurst, Diana Graus Porta, Carolina Haefliger, Bo Han +14 more | 2019-12-17 |
| 10370375 | Heterocyclyl-substituted cyclohexylsulfonamides as JAK inhibitors | Noelle Gauvry, Chouaib Tahtaoui, Pierre Ducray | 2019-08-06 |
| 10202371 | Oxazolidin-2-one-pyrimidine derivatives and the use thereof as phosphatidylinositol-3-kinase inhibitors | Robin Alec Fairhurst, Frank Stephen Kalthoff, Andreas Lerchner, Heinrich Rueeger | 2019-02-12 |
| 10189813 | Formylated N-heterocyclic derivatives as FGFR4 inhibitors | Nicole Buschmann, Robin Alec Fairhurst, Thomas Knoepfel, Catherine Leblanc, Robert Mah | 2019-01-29 |
| 10130629 | Pharmaceutical combinations | Nicole Buschmann, Robin Alec Fairhurst, Jorge Garcia Fortanet, Diana Graus Porta, Nafeeza Hafeez +11 more | 2018-11-20 |
| 10059709 | Compounds | Noelle Gauvry, Chouaib Tahtaoui, Pierre Ducray | 2018-08-28 |
| 9949979 | Use of inhibitors of the activity or function of PI3K | Nigel Graham Cooke, Paulo Fernandes Gomes Dos Santos, Christina Hebach, Klemens Hoegenauer, Gregory John Hollingworth +11 more | 2018-04-24 |
| 9896449 | Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors | Nicole Buschmann, Robin Alec Fairhurst, Thomas Knöpfel, Catherine Leblanc, Lv Liao +7 more | 2018-02-20 |
| 9896444 | Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 | Robert M. Grotzfeld, Wolfgang Jahnke, Darryl Brynley Jones, Paul W. Manley, Andreas Marzinzik +3 more | 2018-02-20 |
| 9802917 | Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide | Nicole Buschmann, Robin Alec Fairhurst, Bo Han, Thomas Knöpfel, Catherine Leblanc +7 more | 2017-10-31 |
| 9795596 | Pharmaceutical diagnostic | Christine Fritsch, Sauveur-Michel Maira | 2017-10-24 |
| 9763952 | Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives | Giorgio Caravatti, Sylvie Chamoin, Klemens Hogenauer, Konstanze Hurth, Karen KAMMERTOENS +6 more | 2017-09-19 |
| 9751876 | Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension | Ian Bruce, Sylvie Chamoin, Stephen Paul Collingwood, Vikki Furminger, Diana Janus +9 more | 2017-09-05 |
| 9556180 | Pyrazolo[3,4-d]pyrimidinone compounds as inhibitors of the P53/MDM2 interaction | Vito Guagnano, Philipp Holzer, Joerg Kallen, Robert Mah, Keiichi Masuya +2 more | 2017-01-31 |
| 9539260 | Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives | Giorgio Caravatti, Sylvie Chamoin, Klemens Hogenauer, Konstanze Hurth, Karen KAMMERTOENS +6 more | 2017-01-10 |
| 9533988 | Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors | Nicole Buschmann, Robin Alec Fairhurst, Thomas Knöpfel, Catherine Leblanc, Lv Liao +7 more | 2017-01-03 |
| 9458112 | Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 | Robert M. Grotzfeld, Wolfgang Jahnke, Darryl Brynley Jones, Paul W. Manley, Andreas Marzinzik +4 more | 2016-10-04 |
| 9458177 | Oxazolidin-2-one compounds and uses thereof | Giorgio Caravatti, Robin Alec Fairhurst, Clive McCarthy, Heinrich Rueeger, Frank Hans Seiler +1 more | 2016-10-04 |
| 9403827 | Substituted purinone compounds | Vito Guagnano, Philipp Holzer, Joerg Kallen, Robert Mah, Keiichi Masuya +2 more | 2016-08-02 |
| 9365576 | Pyrrolopyrrolidinone compounds | Simona Cotesta, Vito Guagnano, Philipp Holzer, Joerg Kallen, Robert Mah +4 more | 2016-06-14 |
| 9340537 | Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 | Robert M. Grotzfeld, Wolfgang Jahnke, Darryl Brynley Jones, Paul W. Manley, Andreas Marzinzik +3 more | 2016-05-17 |
| 9334271 | Purine derivatives and their use in the treatment of disease | Emmanuelle Briard, Andreas Lerchner, Peter Meier, Branko Radetich, David Andrew Sandham +1 more | 2016-05-10 |
| 9315489 | Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 | Robert M. Grotzfeld, Wolfgang Jahnke, Darryl Brynley Jones, Paul W. Manley, Andreas Marzinzik +4 more | 2016-04-19 |